NMR structure of the bovine prion protein

被引:330
作者
Garcia, FL [1 ]
Zahn, R [1 ]
Riek, R [1 ]
Wüthrich, K [1 ]
机构
[1] ETH Honggerberg, Inst Mol Biol & Biophys, CH-8093 Zurich, Switzerland
关键词
D O I
10.1073/pnas.97.15.8334
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The NMR structures of the recombinant 217-residue polypeptide chain C-terminal fragment, bPrP(121-230). include a globular domain extending from residue 125 to residue 227. a short flexible chain end of residues 228-230, and an N-terminal flexibly disordered "tail" comprising 108 residues for the intact protein and 4 residues for bPrP(121-230), respectively. The globular domain contains three alpha-helices comprising the residues 144-154, 173-194 and 200-226, and a short antiparallel beta-sheet comprising the residues 128-131 and 161-164. The best-defined parts of the globular domain are the central portions of the helices 2 and 3. which are linked by the only disulfide bond in bPrP. Significantly increased disorder and mobility is observed for helix 1. the loop 166-172 leading from the beta-strand 2 to helix 2, the end of helix 2 and the following loop, and the last turn of helix 3. Although there are characteristic local differences relative to the conformations of the murine and Syrian hamster prion proteins, the bPrP structure is essentially identical to that of the human prion protein. On the other hand, there are differences between bovine and human PrP in the surface distribution of electrostatic charges, which then appears to be the principal structural feature of the "healthy" PrP form that might affect the stringency of the species barrier for transmission of prion diseases between humans and cattle.
引用
收藏
页码:8334 / 8339
页数:6
相关论文
共 44 条
[1]   DOES AGENT OF SCRAPIE REPLICATE WITHOUT NUCLEIC ACID [J].
ALPER, T ;
CRAMP, WA ;
HAIG, DA ;
CLARKE, MC .
NATURE, 1967, 214 (5090) :764-&
[2]   PRIMARY STRUCTURE EFFECTS ON PEPTIDE GROUP HYDROGEN-EXCHANGE [J].
BAI, YW ;
MILNE, JS ;
MAYNE, L ;
ENGLANDER, SW .
PROTEINS-STRUCTURE FUNCTION AND GENETICS, 1993, 17 (01) :75-86
[3]   METHODOLOGICAL ADVANCES IN PROTEIN NMR [J].
BAX, A ;
GRZESIEK, S .
ACCOUNTS OF CHEMICAL RESEARCH, 1993, 26 (04) :131-138
[4]   Prion protein NMR structure and species barrier for prion diseases [J].
Billeter, M ;
Riek, R ;
Wider, G ;
Hornemann, S ;
Glockshuber, R ;
Wuthrich, K .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (14) :7281-7285
[5]   COMPARISON OF THE HIGH-RESOLUTION STRUCTURES OF THE ALPHA-AMYLASE INHIBITOR TENDAMISTAT DETERMINED BY NUCLEAR MAGNETIC-RESONANCE IN SOLUTION AND BY X-RAY-DIFFRACTION IN SINGLE-CRYSTALS [J].
BILLETER, M ;
KLINE, AD ;
BRAUN, W ;
HUBER, R ;
WUTHRICH, K .
JOURNAL OF MOLECULAR BIOLOGY, 1989, 206 (04) :677-687
[6]   Natural and experimental oral infection of nonhuman primates by bovine spongiform encephalopathy agents [J].
Bons, N ;
Mestre-Frances, N ;
Belli, P ;
Cathala, F ;
Gajdusek, DC ;
Brown, P .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (07) :4046-4051
[7]   Transmissions to mice indicate that 'new variant' CJD is caused by the BSE agent [J].
Bruce, ME ;
Will, RG ;
Ironside, JW ;
McConnell, I ;
Drummond, D ;
Suttie, A ;
McCardle, L ;
Chree, A ;
Hope, J ;
Birkett, C ;
Cousens, S ;
Fraser, H ;
Bostock, CJ .
NATURE, 1997, 389 (6650) :498-501
[8]   NMR structures of three single-residue variants of the human prion protein [J].
Calzolai, L ;
Lysek, DA ;
Güntert, P ;
von Schroetter, C ;
Riek, R ;
Zahn, R ;
Wüthrich, K .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (15) :8340-8345
[9]  
CASE DA, 1997, AMBER 5 0
[10]   Molecular analysis of prion strain variation and the aetiology of 'new variant' CJD [J].
Collinge, J ;
Sidle, KCL ;
Meads, J ;
Ironside, J ;
Hill, AF .
NATURE, 1996, 383 (6602) :685-690